이희진 조교수
#병리과
|
학력
2010 .03 ~ 2012 .02울산대학교 의학 박사
2007 .03 ~ 2009 .08울산대학교 의학 석사
1998 .03 ~ 2004 .02이화여자대학교 의학 학사
2007 .03 ~ 2009 .08울산대학교 의학 석사
1998 .03 ~ 2004 .02이화여자대학교 의학 학사
경력
2016 .03 ~ 현재서울아산병원 병리과 조교수
2013 .03 ~ 2016 .02서울아산병원 병리과 임상전임강사
2012 .03 ~ 2013 .02분당서울대학교병원 병리과 진료교수
2010 .03 ~ 2012 .02서울아산병원 병리과 임상강사(전임의, 펠로우)
2013 .03 ~ 2016 .02서울아산병원 병리과 임상전임강사
2012 .03 ~ 2013 .02분당서울대학교병원 병리과 진료교수
2010 .03 ~ 2012 .02서울아산병원 병리과 임상강사(전임의, 펠로우)
논문
Port-site recurrence 6 years after laparoscopic surgery for early stage ovarian borderline malignancy.
Predicting the level of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer:
Usefulness of breast MRI computer-aided detection and diagnosis.
ADAR1 expression is associated with tumour-infiltrating lymphocytes in triple-negative breast cancer.
Expansion of tumor-infiltrating lymphocytes and their potential for application as adoptive cell transfer therapy in human breast cancer.
Expression of Myxovirus Resistance A (MxA) Is Associated with Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancers.
Expression of the MHC class II in triple-negative breast cancer is associated with tumor-infiltrating lymphocytes and interferon signaling.
Glutaminase expression is a poor prognostic factor in node-positive triple-negative breast cancer patients with a high level of tumor-infiltrating lymphocytes.
Activation of the PERK-eIF2α Pathway Is Associated with Tumor-infiltrating Lymphocytes in HER2-Positive Breast Cancer
Cytoplasmic expression of high mobility group B1 (HMGB1) is associated with tumor-infiltrating lymphocytes (TILs) in breast cancer.
Endoplasmic reticulum stress induces secretion of high-mobility group proteins and is associated with tumor-infiltrating lymphocytes in triple-negative breast cancer.
Expression of Myxovirus Resistance A (MxA) is Associated with Tumor-Infiltrating Lymphocytes (TILs) in Human Epidermal Growth Factor Receptor 2(HER2)-Positive Breast Cancers.
Frequency of MED12 Mutation in Phyllodes Tumours: Inverse correlation with histologic grade.
Phase II trial of neoadjuvant letrozole and lapatinib in Asian postmenopausal women with estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2)-positive breast cancer [Neo-ALL-IN]:
Highlighting the TILs, ER expressional change aft
Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer.
Significance of EZH2 expression in canine mammary tumors.
The Role of High-Resolution Magic Angle Spinning 1H Nuclear Magnetic Resonance Spectroscopy for Predicting the Invasive Component in Patients with Ductal Carcinoma In Situ Diagnosed on Preoperative Biopsy.
Ataxia-Telangiectasia and RAD3-Related and Ataxia-Telangiectasia-Mutated Proteins in Epithelial Ovarian Carcinoma: Their Expression and Clinical Significance.
Cancer-Testis Antigen Expression in Serous Endometrial Cancer with Loss of X Chromosome Inactivation.
Clinicopathologic Significance of the Intratumoral Heterogeneity of HER2 Gene Amplification in HER2-Positive Breast Cancer Patients Treated With Adjuvant Trastuzumab
Comparison of Pathologic Response Evaluation Systems after Anthracycline with/without Taxane-Based Neoadjuvant Chemotherapy among Different Subtypes of Breast Cancers
Dysregulation of X chromosome inactivation in high grade ovarian serous adenocarcinoma.
Expression of NY-ESO-1 in Triple-Negative Breast Cancer Is Associated with Tumor-Infiltrating Lymphocytes and a Good Prognosis.
High mobility group B1 and N1 (HMGB1 and HMGN1) are associated with tumor-infiltrating lymphocytes in HER2-positive breast cancers
Prognostic Factors for Distant Metastasis in Patients with Locoregional Recurrence after Mastectomy
Prognostic Significance of Tumor-Infiltrating Lymphocytes and the Tertiary Lymphoid Structures in HER2-Positive Breast Cancer Treated With Adjuvant Trastuzumab.
Prognostic and predictive value of NanoString-based immune-related gene signatures in a neoadjuvant setting of triple-negative breast cancer: relationship to tumor-infiltrating lymphocytes.
Prognostic factors and outcome analysis of salivary duct carcinoma.
Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer
Correlations between molecular subtypes and pathologic response patterns of breast cancers after neoadjuvant chemotherapy.
Current treatment of early breast cancer: adjuvant and neoadjuvant therapy.
Predicting the level of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer:
Usefulness of breast MRI computer-aided detection and diagnosis.
ADAR1 expression is associated with tumour-infiltrating lymphocytes in triple-negative breast cancer.
Expansion of tumor-infiltrating lymphocytes and their potential for application as adoptive cell transfer therapy in human breast cancer.
Expression of Myxovirus Resistance A (MxA) Is Associated with Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancers.
Expression of the MHC class II in triple-negative breast cancer is associated with tumor-infiltrating lymphocytes and interferon signaling.
Glutaminase expression is a poor prognostic factor in node-positive triple-negative breast cancer patients with a high level of tumor-infiltrating lymphocytes.
Activation of the PERK-eIF2α Pathway Is Associated with Tumor-infiltrating Lymphocytes in HER2-Positive Breast Cancer
Cytoplasmic expression of high mobility group B1 (HMGB1) is associated with tumor-infiltrating lymphocytes (TILs) in breast cancer.
Endoplasmic reticulum stress induces secretion of high-mobility group proteins and is associated with tumor-infiltrating lymphocytes in triple-negative breast cancer.
Expression of Myxovirus Resistance A (MxA) is Associated with Tumor-Infiltrating Lymphocytes (TILs) in Human Epidermal Growth Factor Receptor 2(HER2)-Positive Breast Cancers.
Frequency of MED12 Mutation in Phyllodes Tumours: Inverse correlation with histologic grade.
Phase II trial of neoadjuvant letrozole and lapatinib in Asian postmenopausal women with estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2)-positive breast cancer [Neo-ALL-IN]:
Highlighting the TILs, ER expressional change aft
Predictive Value of Tertiary Lymphoid Structures Assessed by High Endothelial Venule Counts in the Neoadjuvant Setting of Triple-Negative Breast Cancer.
Significance of EZH2 expression in canine mammary tumors.
The Role of High-Resolution Magic Angle Spinning 1H Nuclear Magnetic Resonance Spectroscopy for Predicting the Invasive Component in Patients with Ductal Carcinoma In Situ Diagnosed on Preoperative Biopsy.
Ataxia-Telangiectasia and RAD3-Related and Ataxia-Telangiectasia-Mutated Proteins in Epithelial Ovarian Carcinoma: Their Expression and Clinical Significance.
Cancer-Testis Antigen Expression in Serous Endometrial Cancer with Loss of X Chromosome Inactivation.
Clinicopathologic Significance of the Intratumoral Heterogeneity of HER2 Gene Amplification in HER2-Positive Breast Cancer Patients Treated With Adjuvant Trastuzumab
Comparison of Pathologic Response Evaluation Systems after Anthracycline with/without Taxane-Based Neoadjuvant Chemotherapy among Different Subtypes of Breast Cancers
Dysregulation of X chromosome inactivation in high grade ovarian serous adenocarcinoma.
Expression of NY-ESO-1 in Triple-Negative Breast Cancer Is Associated with Tumor-Infiltrating Lymphocytes and a Good Prognosis.
High mobility group B1 and N1 (HMGB1 and HMGN1) are associated with tumor-infiltrating lymphocytes in HER2-positive breast cancers
Prognostic Factors for Distant Metastasis in Patients with Locoregional Recurrence after Mastectomy
Prognostic Significance of Tumor-Infiltrating Lymphocytes and the Tertiary Lymphoid Structures in HER2-Positive Breast Cancer Treated With Adjuvant Trastuzumab.
Prognostic and predictive value of NanoString-based immune-related gene signatures in a neoadjuvant setting of triple-negative breast cancer: relationship to tumor-infiltrating lymphocytes.
Prognostic factors and outcome analysis of salivary duct carcinoma.
Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer
Correlations between molecular subtypes and pathologic response patterns of breast cancers after neoadjuvant chemotherapy.
Current treatment of early breast cancer: adjuvant and neoadjuvant therapy.
저서
저서 내용이 없습니다.
보도자료
보도자료 내용이 없습니다.
포스팅
FcrR3A-158 polymorphism and stromal tumor-infiltrating lymphocytes as predictive markers for trastuzumab-based treatment in patients with metastatic HER2-positive breast cancer
Predictive role of stromal tumor infiltrating lymphocytes (TILs) in patients with metastatic HER2-positive breast cancer (BC) treated with trastuzumab
Differential Expression of Major Histocompatibility Complex I in Subtypes of Breast Cancer
Differential Expression of Major Histocompatibility Complex I in Subtypes of Breast Cancer
Predictive role of stromal tumor infiltrating lymphocytes (TILs) in patients with metastatic HER2-positive breast cancer (BC) treated with trastuzumab
Differential Expression of Major Histocompatibility Complex I in Subtypes of Breast Cancer
Differential Expression of Major Histocompatibility Complex I in Subtypes of Breast Cancer
영상자료
영상자료 내용이 없습니다.
발표자료
발표자료 내용이 없습니다.